UGT1A1*28/*28 genotype and risk of toxicity and disease progression in breast cancer patients treated with sacituzumab govitecan-hziy-MedSci.cn

UGT1A128/28 genotype and risk of toxicity and disease progression in breast cancer patients treated with sacituzumab govitecan-hziy

Wong, M; Behrendt, CE; Yu, W; Bosserman, LD; Lavasani, SM; Patel, N; Sedrak, MS; Stewart, DB; Waisman, JR; Yuan, Y; Mortimer, JE

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

科室
- - 订阅+
  - 更多科室
工具
服务